Enveric Biosciences (ENVB) News Today $0.69 -0.01 (-1.29%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$0.67 -0.02 (-2.66%) As of 04:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENVB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Enveric Biosciences' (ENVB) Sell (E+) Rating Reaffirmed at Weiss Ratings3 hours ago | americanbankingnews.comPsychedelic: Enveric announces EB-003 manufacturing milestonesOctober 2, 2025 | msn.comEnveric Biosciences completes key manufacturing milestones for EB-003October 2, 2025 | msn.comEnveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical TrialsOctober 2, 2025 | businesswire.comEnveric Biosciences (NASDAQ:ENVB) Shares Up 3.5% - Here's WhyOctober 2, 2025 | americanbankingnews.comEnveric Biosciences files to sell 5.02M shares of common stock for holdersSeptember 29, 2025 | msn.comEnveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross ProceedsSeptember 18, 2025 | businesswire.comEnveric Biosciences publishes two peer-reviewed research papersSeptember 17, 2025 | msn.comEnveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross ProceedsSeptember 17, 2025 | businesswire.comEnveric Biosciences receives FDA response, streamlines path for EB-003September 16, 2025 | msn.comEnveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND SubmissionSeptember 16, 2025 | businesswire.comEnveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 5, 2025 | finance.yahoo.comEnveric Biosciences Releases New Investor PresentationAugust 29, 2025 | tipranks.comEnveric Tanks on Successful TestsAugust 28, 2025 | baystreet.caEnveric Biosciences Announces Preclinical Results Confirming Potential ...August 17, 2025 | businesswire.comEnveric Biosciences Reports Second Quarter 2025 Financial and Corporate ResultsAugust 15, 2025 | finance.yahoo.comEnveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 SeriesJuly 23, 2025 | finance.yahoo.comEnveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 SeriesJuly 23, 2025 | businesswire.comEnveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)July 15, 2025 | businesswire.comEnveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003 - MorningstarJune 26, 2025 | morningstar.comMEnveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric DisordersJune 10, 2025 | businesswire.comEnveric Biosciences secures patent for sleep disorder moleculesJune 4, 2025 | investing.comEnveric Biosciences announces results from EB-003 trialMay 29, 2025 | finance.yahoo.comEnveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003May 28, 2025 | finance.yahoo.comEnveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative DiseaseMay 20, 2025 | finance.yahoo.comEnveric Biosciences Reports First Quarter 2025 Financial and Corporate ResultsMay 14, 2025 | businesswire.comEnveric Biosciences Participating in BIO-Europe Spring®March 17, 2025 | businesswire.comEnveric Biosciences to auction PsyAI trademark portfolioMarch 8, 2025 | uk.investing.comEnveric Biosciences launches RFP solicitation process for PsyAI trademarkMarch 6, 2025 | markets.businessinsider.comEnveric Biosciences CEO Issues Letter to ShareholdersFebruary 27, 2025 | businesswire.comThis Biotech Soared On Key AnnouncementFebruary 26, 2025 | msn.comEnveric Biosciences Unveils EVM401 Series of Compounds with New U.S. PatentFebruary 25, 2025 | businesswire.comPsychedelic: Exclusive talk with biotech company Enveric BiosciencesFebruary 20, 2025 | markets.businessinsider.comENVB stock touches 52-week low at $1.51 amid market challengesFebruary 11, 2025 | msn.comEnveric Biosciences unit in licensing pacts with Restoration BiologicsFebruary 5, 2025 | markets.businessinsider.comEnveric Biosciences Down Sharply After Public OfferingJanuary 31, 2025 | marketwatch.comEnveric Biosciences stock plummets after pricing $5M capital raiseJanuary 31, 2025 | msn.comEnveric Biosciences Announces Pricing of $5 Million Public OfferingJanuary 30, 2025 | businesswire.comEnveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark OfficeJanuary 30, 2025 | businesswire.comEnveric Biosciences files to sell common stock, warrants, no amount givenJanuary 15, 2025 | markets.businessinsider.comEnveric's Pre-clinical Study Of EB-003 Shows Bioavailability, Brain Penetration In Animal StudiesNovember 25, 2024 | markets.businessinsider.comEnveric Biosciences Reports Third Quarter 2024 Financial and Corporate ResultsNovember 14, 2024 | businesswire.comEnveric in out-licensing deal with MycoMedica Life for EB-002November 13, 2024 | markets.businessinsider.comEnveric Biosciences Out-Licenses Key Program To MycoMedica In $62M DealNovember 13, 2024 | benzinga.comEnveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002November 13, 2024 | finance.yahoo.comEnveric Biosciences Expands Mental Health Patent Portfolio With 5 New AdditionsNovember 5, 2024 | msn.comEnveric Biosciences Announces Broad Range of Patent IssuancesNovember 4, 2024 | businesswire.comEnveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | finance.yahoo.comEnveric Biosciences, Inc. (ENVB)August 26, 2024 | nz.finance.yahoo.comEnveric secures patent for radiation dermatitis topical productAugust 15, 2024 | uk.investing.com Get Enveric Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENVB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ENVB Media Mentions By Week ENVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENVB News Sentiment▼0.170.63▲Average Medical News Sentiment ENVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENVB Articles This Week▼41▲ENVB Articles Average Week Get the Latest News and Ratings for ENVB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies HCWB News CAPS News GOVX News BCDA News PRTG News BMRA News NBY News BCLI News ENTO News PALI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ENVB) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
